Plain-English translation of NCT06501222 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a technique called remote ischemic preconditioning (RIC), which involves briefly inflating a blood pressure cuff on your arms to create a temporary reduction in blood flow. The idea is that this triggers your body's natural protective mechanisms, which may help your kidneys become more resistant to damage and slow the progression of chronic kidney disease.
Chronic kidney disease is becoming more common and can lead to serious complications, but current treatments only slow its progression and don't reverse the damage. Researchers want to explore whether this non-invasive arm-squeezing technique could offer a new way to protect kidneys and prevent further decline in kidney function.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either the active treatment or a control version. The treatment involves sitting comfortably while an automated device inflates a blood pressure cuff on both of your upper arms repeatedly—either to a higher pressure (active group) or a lower pressure (control group)—for five-minute cycles, five times in a row. The study team will monitor your kidney function over time with blood and urine tests to see if the treatment helps slow disease progression.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
China